Target intelligence / Profile preview

MAPRE3 antisense RNA 1 (MAPRE3-AS1)

Target
MAPRE3-AS1
Molecular classification
Other, Long non-coding RNA (lncRNA)
01

Overview

MAPRE3 antisense RNA 1 (MAPRE3-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand of the MAPRE3 locus on human chromosome 2[4]. lncRNAs of this type generally function in the regulation of local or distant gene expression through mechanisms such as transcriptional interference, chromatin remodeling, or modulation of mRNA stability or translation[3]. However, there is no specific peer-reviewed functional or clinical annotation for MAPRE3-AS1 itself in standard databases as of 2025. Its expression, role in health or disease, and utility as a drug target remain unclear in current biomedical literature[4][3]. MAPRE3 (without the "-AS1") refers to a protein-coding gene: Microtubule-associated protein RP/EB family member 3, with well-characterized molecular and biological functions[2][5][7][8]. MAPRE3-AS1 is distinct and does not encode a protein, nor is it known to have "receptor", "enzyme", or similarly druggable target properties. The classification as a therapeutic target ("is_target") is set to false, as there is currently no evidence supporting its use as a direct target for pharmacological intervention or biomarker for patient selection.

02

Mechanism of action

null

03

Biological functions

Putative gene expression regulation (based on general knowledge of antisense RNAs)
04

Disease associations

Other

Beyond the preview

Go deeper on MAPRE3 antisense RNA 1 (MAPRE3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAPRE3 antisense RNA 1 (MAPRE3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call